DHX15 is involved in SUGP1-mediated RNA missplicing by mutant SF3B1 in cancer

Author:

Zhang Jian1ORCID,Huang Ji1ORCID,Xu Ke1,Xing Peiqi2ORCID,Huang Yue23,Liu Zhaoqi23ORCID,Tong Liang1ORCID,Manley James L.1

Affiliation:

1. Department of Biological Sciences, Columbia University, New York, NY 10027

2. Chinese Academy of Sciences Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences and China National Center for Bioinformation, Beijing 100101, China

3. University of Chinese Academy of Sciences, Beijing 100049, China

Abstract

SF3B1 is the most frequently mutated spliceosomal gene in cancer. Several hotspot mutations are known to disrupt the interaction of SF3B1 with another splicing factor, SUGP1, resulting in the RNA missplicing that characterizes mutant SF3B1 cancers. Properties of SUGP1, especially the presence of a G-patch motif, a structure known to function by activating DEAH-box RNA helicases, suggest the requirement of such an enzyme in SUGP1 function in splicing. However, the identity of this putative helicase has remained an important unanswered question. Here, using a variety of protein–protein interaction assays, we identify DHX15 as the critical helicase. We further show that depletion of DHX15 or expression of any of several DHX15 mutants, including one implicated in acute myeloid leukemia, partially recapitulates the splicing defects of mutant SF3B1. Moreover, a DHX15-SUGP1 G-patch fusion protein is able to incorporate into the spliceosome to rescue the splicing defects of mutant SF3B1. We also present the crystal structure of the human DHX15-SUGP1 G-patch complex, which reveals the molecular basis of their direct interaction. Our data thus demonstrate that DHX15 is the RNA helicase that functions with SUGP1 and additionally provide important insight into how mutant SF3B1 disrupts splicing in cancer.

Funder

HHS | National Institutes of Health

National Natural Science Foundation of China

Chinese Academy of Sciences Hundred Talents Program

Celgene Pharmaceutical Company

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Dynamic interactions drive early spliceosome assembly;Current Opinion in Structural Biology;2024-10

2. DHX15 inhibits mouse APOBEC3 deamination;2024-08-19

3. Molecular impact of mutations in RNA splicing factors in cancer;Molecular Cell;2024-08

4. Understanding the dynamic design of the spliceosome;Trends in Biochemical Sciences;2024-07

5. (G)Patching up mis-splicing in cancer;Trends in Biochemical Sciences;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3